PetDx Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 86

Employees

  • Latest Deal Type
  • M&A

PetDx General Information

Description

Developer of a liquid biopsy technology designed to revolutionize the early detection of cancer in pets. The company's technology is focused on non-invasive tests with customized assays and sequencing-based techniques, enabling veterinarians to early detect, characterize, and manage cancer cells in pets.

Contact Information

Website
www.petdx.com
Formerly Known As
4Paws Dx
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 9310 Athena Circle
  • Suite 230
  • La Jolla, CA 92037
  • United States
+1 (858)
Primary Industry
Other Commercial Products
Corporate Office
  • 9310 Athena Circle
  • Suite 230
  • La Jolla, CA 92037
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PetDx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Early Stage VC 01-Sep-2022 Completed Generating Revenue
3. Early Stage VC (Series B) 10-Sep-2021 Completed Generating Revenue
2. Early Stage VC (Series A) 31-Jul-2020 $9.8M $9.8M Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view PetDx’s complete valuation and funding history, request access »

PetDx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1
Series B-2
Series A 8,881,790 $0.000010 6% $1.22 $1.22 1x $1.22 23.23%
To view PetDx’s complete cap table history, request access »

PetDx Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a liquid biopsy technology designed to revolutionize the early detection of cancer in pets. The company's t
Other Commercial Products
La Jolla, CA
86 As of 2023

Brisbane, CA
 

Palo Alto, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PetDx Competitors (5)

One of PetDx’s 5 competitors is Freenome, a Formerly VC-backed company based in Brisbane, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Freenome Formerly VC-backed Brisbane, CA
FidoCure Venture Capital-Backed Palo Alto, CA
GRAIL Formerly VC-backed Menlo Park, CA
VolitionRx Corporation Henderson, NV
Vidium Animal Health Corporation Phoenix, AZ
You’re viewing 5 of 5 competitors. Get the full list »

PetDx Patents

PetDx Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024097217-A1 Detection of non-cancer somatic mutations Inactive 01-Nov-2022
CA-3219753-A1 Methods and compositions for detecting cancer using fragmentomics Pending 21-May-2021
JP-2024519975-A Methods and compositions for detecting cancer using fragmentomics Pending 21-May-2021
WO-2022246232-A1 Methods and compositions for detecting cancer using fragmentomics Inactive 21-May-2021
WO-2021126997-A1 Methods and compositions for cancer detection, characterization or management in companion animals Inactive 18-Dec-2019 C12Q1/6886
To view PetDx’s complete patent history, request access »

PetDx Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PetDx Former Investors (18)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aperture Venture Partners Venture Capital Minority
Black Granite Capital Growth/Expansion Minority
CONNECT (San Diego) Accelerator/Incubator Minority
Declaration Partners Growth/Expansion Minority
Divergent Investments Impact Investing Minority
You’re viewing 5 of 18 investors. Get the full list »

PetDx FAQs

  • When was PetDx founded?

    PetDx was founded in 2019.

  • Where is PetDx headquartered?

    PetDx is headquartered in La Jolla, CA.

  • What is the size of PetDx?

    PetDx has 86 total employees.

  • What industry is PetDx in?

    PetDx’s primary industry is Other Commercial Products.

  • Is PetDx a private or public company?

    PetDx is a Private company.

  • What is PetDx’s current revenue?

    The current revenue for PetDx is .

  • How much funding has PetDx raised over time?

    PetDx has raised $71.8M.

  • Who are PetDx’s investors?

    Aperture Venture Partners, Black Granite Capital, CONNECT (San Diego), Declaration Partners, and Divergent Investments are 5 of 18 investors who have invested in PetDx.

  • Who are PetDx’s competitors?

    Freenome, FidoCure, GRAIL, VolitionRx, and Vidium Animal Health are competitors of PetDx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process